• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—July 2

    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser

    Pancryos Forges License Agreement for Microencapsulation Device

    FDA Awards IDE Approval to SELUTION SLR Drug-Eluting Balloon

    Matt Rainville Joins Bigfoot Biomedical as Chief Commercial Officer
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Theranos Fraud Trial, Part II: The Blame Game Continues

    An Update on Surgical Robotics

    Letting the Light In: How Failure Analysis is the Cornerstone of Success

    Three Talent Strategies to Attract High-Demand Skills

    The Advantages of Bioburden Screening for Sterilization Validation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Concise Engineering

    Fusion Biotec Inc.

    Trademark Plastics Inc.

    BMP Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    ‘Right to Repair’: Separating Fact from Fiction

    Taking a Holistic Approach to Decentralized Clinical Trials (DCTs)

    Investment in Health Startups Drops

    The Power of Leveraging Customer Relationships

    Cost Effective & Efficient Wire EDM Techniques
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    Concise Engineering

    Fusion Biotec Inc.

    Trademark Plastics Inc.

    BMP Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Former Chief Medical Officer of Celgene Joins BioSig Technologies Board of Directors

    New board member is a named inventor on 43 U.S. patents, has published 122 peer reviewed articles and 24 reviews, book chapters, and editorials.

    Related CONTENT
    • Former Chief Medical Officer of Celgene Joins BioSig Board of Directors
    • BioSig Awarded U.S. Patent for PURE EP Simulator
    • J&J's Ethicon Acquires Takeda's TachoSil Surgical Patch for $400M
    • California Investor and Recording Artist Joins BioSig Technologies Advisory Board
    • BioSig Appoints Vice President of Engineering
    Globe Newswire07.09.19
    BioSig Technologies Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, said Dr. Jerome B. Zeldis, M.D., Ph.D., has re-joined the company as an independent director.  
     
    Zeldis brings extensive life sciences experience gained primarily through his career at Celgene Inc. He previously served as CEO of Celgene Global Health and chief medical officer of Celgene Corporation, a publicly traded, fully integrated biopharmaceutical company, where he was employed for nearly 20 years, starting in 1997. Celgene Corporation’s Board of Directors and shareholders have approved an offer to be acquired by Bristol Myers-Squibb in a cash and stock deal valued at $74 billion at the time of the offer.
     
    “I am very pleased with the progress that has occurred from the time I left the Board until now,” commented Dr. Zeldis. “I look forward to the realization of the clinical benefit that may occur by reducing noise in a variety of settings in which detection of small signals is critical for therapeutic interventions.”
     
    Since 2016, Dr. Zeldis has served as chief medical officer and president of Clinical Research, Medical Affairs Drug Safety, Quality, and Regulatory at Sorrento Therapeutics Inc. He attended Brown University for an AB, MS, followed by Yale University for a MPhil, M.D., Ph.D. in molecular biophysics and biochemistry. Dr. Zeldis trained in internal medicine at the UCLA Center for the Health Sciences and in Gastroenterology at the Massachusetts General Hospital and Harvard Medical School. He was assistant professor of medicine at the Harvard Medical School, associate professor of medicine at University of California, Davis, clinical associate professor of medicine at Cornell Medical School, and professor of clinical medicine at the Robert Wood Johnson Medical School in New Brunswick, N.J. Dr. Zeldis is a named inventor on 43 U.S. patents, has published 122 peer reviewed articles and 24 reviews, book chapters, and editorials. 
     
    “Dr. Zeldis is one of our earliest investors and has watched our company grow from the beginning. He continues to invest in the company. We are eager to work with him to capitalize on his experience in clinical development, regulatory strategy, shareholder wealth creation, and platform development. We are especially excited regarding Jerry’s understanding of bioelectronic medicine and how our PURE EP System can contribute to this rapidly emerging field,” stated Kenneth L. Londoner, founder, chairman and CEO of BioSig Technologies Inc.
     
    BioSig has successfully conducted first patient cases using its PURE EP System at the Texas Cardiac Arrhythmia Institute in Austin, Greenville Memorial Hospital in Greenville, S.C., and Indiana University School of Medicine. These initial experiences suggested improved cardiac signal detection and fidelity. 

    BioSig Technologies is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. Led by a management team and a veteran Board of Directors, BioSig Technologies is preparing to commercialize its PURE EP System. The technology has been developed to address an unmet need in a large and growing market. The company’s first product, the PURE EP System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The system is indicated for use under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. This cardiac signal acquisition and display system is engineered to assist electrophysiologists in clinical decision-making during electrophysiology procedures in patients with abnormal heart rates and rhythms. BioSig’s ultimate goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, atrial fibrillation and ventricular tachycardia. BioSig has partnered with Minnetronix on technology development and received U.S. Food and Drug Administration 510(k) clearance for the PURE EP System in August 2018.
    Related Searches
    • safety
    • atrial fibrillation
    • bioelectronic
    • technologies
    Suggested For You
    Former Chief Medical Officer of Celgene Joins BioSig Board of Directors Former Chief Medical Officer of Celgene Joins BioSig Board of Directors
    BioSig Awarded U.S. Patent for PURE EP Simulator BioSig Awarded U.S. Patent for PURE EP Simulator
    J&J J&J's Ethicon Acquires Takeda's TachoSil Surgical Patch for $400M
    California Investor and Recording Artist Joins BioSig Technologies Advisory Board California Investor and Recording Artist Joins BioSig Technologies Advisory Board
    BioSig Appoints Vice President of Engineering BioSig Appoints Vice President of Engineering
    BioSig Announces Successful First-In-Human Use of PURE EP System BioSig Announces Successful First-In-Human Use of PURE EP System
    BioSig Technologies Expands its Engineering Team BioSig Technologies Expands its Engineering Team
    BioSig Announces Successful First-In-Human Use of PURE EP System BioSig Announces Successful First-In-Human Use of PURE EP System
    Electrophysiology Expert Joins BioSig Technologies Management Team Electrophysiology Expert Joins BioSig Technologies Management Team
    BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
    Medical Leaders Join BioSig Clinical Advisory Board Medical Leaders Join BioSig Clinical Advisory Board

    Related Breaking News

    • Cardiovascular
      Former Chief Medical Officer of Celgene Joins BioSig Board of Directors

      Former Chief Medical Officer of Celgene Joins BioSig Board of Directors

      New board member worked for Celgene for nearly 20 years.
      Globe Newswire 07.02.19

    • Cardiovascular
      BioSig Awarded U.S. Patent for PURE EP Simulator

      BioSig Awarded U.S. Patent for PURE EP Simulator

      The allowed claims address a system for determining the accuracy of an EP recorder or a mapping system in the acquisition of cardiac signals.
      Globe Newswire 06.07.19

    • Surgical
      J&J

      J&J's Ethicon Acquires Takeda's TachoSil Surgical Patch for $400M

      In a massive divestment effort, Takeda also agreed to sell Xiidra ophthalmic solution to Novartis for up to $5.3 billion.
      Business Wire 05.10.19


    • California Investor and Recording Artist Joins BioSig Technologies Advisory Board

      California Investor and Recording Artist Joins BioSig Technologies Advisory Board

      Successful business leader to support the company’s business development.
      Globe Newswire 05.07.19

    • Cardiovascular
      BioSig Appoints Vice President of Engineering

      BioSig Appoints Vice President of Engineering

      Medical device technology leader to help drive new product development.
      Globe Newswire 04.18.19

    Loading, Please Wait..

    Trending
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • 7 Steps To Create Your Own Medical Device Marketing Plan
    Breaking News
    • MPO's Most-Read Stories This Week—July 2
    • OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    • Pancryos Forges License Agreement for Microencapsulation Device
    • FDA Awards IDE Approval to SELUTION SLR Drug-Eluting Balloon
    • Matt Rainville Joins Bigfoot Biomedical as Chief Commercial Officer
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • OEMs Seek Molders Offering Timely Techniques
    • Robotic Surgery: Cutting Through to the Latest
    • Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pharmavite Expands in Ohio with $200 Million Investment
    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    Coatings World

    Latest Breaking News From Coatings World

    Azelis Acquires Chemical Partners, Strengthens Leadership in Africa and Middle East
    Emmanuelle Bromet Named Arkema Sustainable Development VP
    ROSS Planetary Dual Dispersers Have Unique Processing Flexibility
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—July 2
    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    Pancryos Forges License Agreement for Microencapsulation Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bayer Opens New Research and Innovation Center at Kendall Square
    Lonza Names Maria Soler Nunez as Head, Group Operations
    Eurofins DiscoverX Opens Shanghai Office
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Dexlevo Introduces Beauty Treatment technique, ‘GOURI’
    Revision Skincare Exec Wins Ernst & Young Entrepreneur of the Year
    Latest Updates About Cosmoprof North America
    Happi

    Latest Breaking News From Happi

    SCOTUS EPA Ruling Won’t Impact General Regulatory Authority
    Toning Collection For Zero-Brass Blondes is New at Colorproof
    Esthetician Studio Beauty Concepts Files Trademark Infringement Lawsuit Against Kim Kardashian and Coty, Inc.
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Flint OPS, Xerox and MNYPIA Top This Week’s News
    Azelis Acquires Chemical Partners, Adds to Leadership in Africa and Middle East
    International Paper Publishes 2021 Sustainability Report
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UPM Raflatac boosts operations in US, All4Labels returns to HP and more
    Fedrigoni Self-Adhesives to exhibit at Labelexpo Americas for first time
    CELAB Europe wins Paper Recycling award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter, Blue Ocean Closures Partner with Absolut
    What You’re Reading on Nonwovens-Industry.com
    Daio, Livedo Partner to Recycle Diapers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—July 2
    NuVasive Inc. Opens Singapore Experience Center
    Pedicle Screw Systems Market to Top $3B in 2027
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Identiv, and Japan Display Top This Week’s Stories
    Epishine is Building a New Solar Cell Factory in Linköping, Sweden
    Toppan Establishes CVC Fund and Investment Management Company in the US

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login